However, this mutation is reported in three studies and found in 18 Fanconi anemia patients, and is associated with BC in the Irish.18, 19 Multigene panel testing is likely to provide a more complete mutation capture than BRCA1/2 alone.9, 20 No pathogenic mutations were found in STK11 and RAD51C. It was also reported that STK11 mutations have been limited to individuals with clinical features indicative of the Peutz‐Jegher syndrome and RAD51C mutations reported in OC.17 Of note, BARD1 and BRIP1 pathogenic mutations were not detected in this study . This evidence concerns the gene BARD1 and breast cancer.